Related Experiment Video
Updated: Mar 18, 2026

08:28
Single-molecule Manipulation of G-quadruplexes by Magnetic Tweezers
Published on: September 19, 2017
8.7K
A 4:1 stoichiometric binding and stabilization of mitoxantrone-parallel stranded G-quadruplex complex established by
Tarikere Palakashan Pradeep1, Ritu Barthwal1
1Department of Biotechnology, Indian Institute of Technology Roorkee, Roorkee 247667, India.
Summary
Small molecule ligands targeting G-quadruplex DNA structures can inhibit cancer-associated telomerase. This study reveals mitoxantrone binds as dimers to G-quadruplex DNA, offering insights into anti-tumor drug efficacy.
Area of Science:
- Biochemistry
- Molecular Biology
- Medicinal Chemistry
Background:
- Telomerase enzyme activity is a key cancer marker.
- Small molecule ligands stabilizing G-quadruplex structures inhibit telomerase.
- Understanding ligand-G-quadruplex binding is crucial for anti-cancer drug development.
Purpose of the Study:
- To investigate the interaction between the anti-tumor drug mitoxantrone (MTX) and a specific tetra-molecular parallel stranded G-quadruplex DNA sequence (d-TTGGGGT).
- To elucidate the binding mode and stoichiometry of mitoxantrone on the G-quadruplex structure.
Main Methods:
- UV-Vis absorbance spectroscopy
- Fluorescence spectroscopy
- Circular Dichroism (CD) spectroscopy
- Proton Nuclear Magnetic Resonance (NMR) spectroscopy
- Thermal melting studies
Main Results:
- Mitoxantrone binding induced significant changes in absorbance and fluorescence spectra, indicating complex formation.
- Spectroscopic data suggested a dual binding mode for mitoxantrone with two distinct binding sites.
- Circular Dichroism and NMR studies confirmed that mitoxantrone binds as stacked dimers.
- Thermal melting studies showed stabilization of the G-quadruplex structure upon mitoxantrone binding.
Conclusions:
- Mitoxantrone binds to the G-quadruplex DNA externally as two dimers (four molecules total) at two distinct sites.
- This specific binding mode provides valuable information for designing effective anti-cancer therapeutics targeting G-quadruplex structures.

